In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $26.95 in the prior trading day, Vera Therapeutics Inc (NASDAQ: VERA) closed at $25.91, down -3.86%. In other words, the price has decreased by -$3.86 from its previous closing price. On the day, 0.9 million shares were traded. VERA stock price reached its highest trading level at $27.17 during the session, while it also had its lowest trading level at $25.79.
Ratios:
Our goal is to gain a better understanding of VERA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 25.58 and its Current Ratio is at 25.58. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 04, 2025, initiated with a Outperform rating and assigned the stock a target price of $49.
On January 28, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $58.
On November 21, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $70.Wells Fargo initiated its Overweight rating on November 21, 2024, with a $70 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 21 ’25 when Fordyce Marshall sold 10,613 shares for $27.89 per share. The transaction valued at 296,032 led to the insider holds 213,740 shares of the business.
Fordyce Marshall sold 9,075 shares of VERA for $250,882 on Feb 26 ’25. The PRESIDENT AND CEO now owns 204,665 shares after completing the transaction at $27.65 per share. On Feb 26 ’25, another insider, MARSHALL FORDYCE, who serves as the Director of the company, bought 9,075 shares for $27.10 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 1718016896 and an Enterprise Value of 1065504192.
Stock Price History:
The Beta on a monthly basis for VERA is 1.21, which has changed by -0.38512433 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, VERA has reached a high of $51.61, while it has fallen to a 52-week low of $25.99. The 50-Day Moving Average of the stock is -17.33%, while the 200-Day Moving Average is calculated to be -32.33%.
Shares Statistics:
The stock has traded on average 845.78K shares per day over the past 3-months and 712990 shares per day over the last 10 days, according to various share statistics. A total of 63.56M shares are outstanding, with a floating share count of 48.94M. Insiders hold about 23.22% of the company’s shares, while institutions hold 91.42% stake in the company. Shares short for VERA as of 1741910400 were 7250076 with a Short Ratio of 8.57, compared to 1739491200 on 8357773. Therefore, it implies a Short% of Shares Outstanding of 7250076 and a Short% of Float of 15.14.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
